Acute and Long-Term Treatment of Catatonia with Risperidone

 

 Buy Article Permissions and Reprints

Catatonia is a rare but difficult-to-treat disorder. Here, we report on the case of a schizophrenic patient who developed several episodes of severe catatonia after suffering from adequately treated Lyme disease with encephalitis. The catatonic stupor was not responsive to typical neuroleptics and benzodiazepines. After the medication was changed to risperidone, there was a dramatic and persistent improvement of the patient's condition. Two relapses during the follow-up period over five years were caused by dose reductions. Risperidone might be a promising drug in the treatment of acute catatonia and in preventing further episodes.

References

• 1 Bahro M, Kampf C, Strnad J. Catatonia under medication with risperidone in a 61-year-old patient.  Acta Psychiatr Scand. 1999;  99 223-224
  PubMedGoogle Scholar
• 2 Barenett W, Sigmund D, Roelcke U, Mundt C. Endomorphes paranoid-halluzinatorisches Syndrom durch Borrelienenzephalitis.  Nervenarzt. 1991;  62 445-447
  PubMedGoogle Scholar
• 3 Blumer D. Catatonia and the neurolepics: psychobiologic significance of remote and recent findings.  Comprehensive Psychiatry. 1997;  38 193-201
  CrossrefPubMedGoogle Scholar
• 4 Brown J S. Geographic correlation of schizophrenia to ticks and tick-borne encephalitis.  Schizophr Bull. 1994;  20 755-775
  PubMedGoogle Scholar
• 5 Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy.  Acta Psychiatr Scand. 1996;  93 137-143
  CrossrefPubMedGoogle Scholar
• 6 Cook E H, Olson K, Pliskin N. Response of organic catatonia to risperidone.  Arch Gen Psychiatry. 1996;  53 82-83
  PubMedGoogle Scholar
• 7 Fallon B A, Nields J A. Lyme disease: a neuropsychiatric illness.  Am J Psychiatry. 1994;  151 1571-1583
  PubMedGoogle Scholar
• 8 Francis A, Divadeenam K M, Bush G, Petrides G. Consistency of symptoms in recurrent catatonia.  Comprehensive Psychiatry. 1997;  38 56-60
  CrossrefPubMedGoogle Scholar
• 9 Hess A, Buchmann J, Zettl U K, Henschel S, Schlaefke D, Grau G, Benecke R. Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder.  Biol Psychiatry. 1999;  45 795
  CrossrefPubMedGoogle Scholar
• 10 Neppe V M. Management with catatonic stupor with L-Dopa.  Clin Neuropharmacol. 1988;  11 90-91
  PubMedGoogle Scholar
• 11 Peralta V, Cuesta M J, Serrano J F, Mata I. The Kahlbaum Syndrome: a study of its clinical validity, nosological status, and relationship with schizophrenia and mood disorder.   Comprehensive Psychiatry. 1997;  38 61-67
  CrossrefPubMedGoogle Scholar
• 12 Poyurousky M, Bergmann J, Weizman A. Risperidone in the treatment of catatonia in a schizophrenic patient.  Isr J Psychiatry Rel Sci. 1997;  34 323-324
  PubMedGoogle Scholar
• 13 Rankel H W, Rankel L E. Carbamazepine in the treatment of catatonia.  Am J Psychiatry. 1988;  145 361-362
  PubMedGoogle Scholar
• 14 Roelcke U, Barnett W, Wilder-Smith E, Sigmund D, Hacke W. Untreated neuroborreliosis: Bannwarth's syndrome evolving into acute schizophrenia-like psychosis. A case report.  J Neurol. 1992;  239 129-131
  PubMedGoogle Scholar
• 15 Rohland B M, Carroll B T, Jakoby R G. ECT in the treatment of the catatonic syndrome.  J Affective Disorders. 1993;  29 255-261
  CrossrefPubMedGoogle Scholar
• 16 Rosebush P I, Hildebrand A M, Furlong B G, Mazurek M F. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.  J Clin Psychiatry. 1990;  51 357-362
  PubMedGoogle Scholar

Dr. C. Normann

Universität Freiburg
Abteilung für Psychiatrie und Psychotherapie

Hauptstrasse 5

79104 Freiburg

Germany